Phase III Study of TS-142 in Patients with Insomnia
Clinical trial NCT05453136 · COMPLETED
Trial details
- NCT number
- NCT05453136
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-30
- Primary completion
- 2023-12-05
- Enrollment
- 1155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.